1. Home
  2. FOR vs NNNN Comparison

FOR vs NNNN Comparison

Compare FOR & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$24.98

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$25.76

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
NNNN
Founded
2005
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
FOR
NNNN
Price
$24.98
$25.76
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$31.75
N/A
AVG Volume (30 Days)
108.9K
21.8K
Earning Date
04-21-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
$1,662,400,000.00
N/A
Revenue This Year
$0.52
N/A
Revenue Next Year
$7.72
N/A
P/E Ratio
$81.50
$446.57
Revenue Growth
10.14
N/A
52 Week Low
$18.00
$5.91
52 Week High
$30.74
$55.65

Technical Indicators

Market Signals
Indicator
FOR
NNNN
Relative Strength Index (RSI) 41.62 55.57
Support Level $24.20 $19.53
Resistance Level $26.06 $30.70
Average True Range (ATR) 0.79 2.17
MACD 0.01 0.53
Stochastic Oscillator 38.60 70.37

Price Performance

Historical Comparison
FOR
NNNN

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: